Healthtech Innovation in LATAM: From 2019 to 2026, What Changed and What Comes Next

In 2019, the FIME (Florida International Medical Expo) published a report that attempted to map the landscape of health technology innovation for Latin America. The global digital health market was valued at $73.1 billion with a compound annual growth rate (CAGR) of 21.1%. Blockchain was in pilot phase at barely 5 to 10% of healthcare institutions, and artificial intelligence applied to healthcare IT represented a market of $1.7 billion. The region invested a meager 0.63% of GDP in research and development, compared to the 2.4% average among OECD countries.

Seven years later, the landscape is radically different. This article traces what that report predicted, what actually happened, and where healthtech innovation in LATAM is headed.

The Starting Point: FIME 2019 Projections

The FIME 2019 report identified clear trends but framed them cautiously. Digital transformation in healthcare was an aspiration more than an operational reality in most countries. The main technological bets included:

• Artificial intelligence: the healthcare AI market was projected to grow from $1.7B to over $10B by 2025, focused primarily on diagnostic imaging and drug discovery.
• Blockchain: mentioned as a potential solution for medical record interoperability, though it acknowledged that only 5-10% of organizations were piloting it.
• Internet of Medical Things (IoMT): connected devices for remote monitoring, with projections of 20-30 billion connected devices globally by 2025.
• Telemedicine: categorized as "emerging" in the region, with use cases concentrated in teleconsultation and teleradiology in a few pioneering countries.

What the report could not anticipate was the most powerful catalyst in recent digital health history: a global pandemic.

The Unforeseen Catalyst: COVID-19

When the WHO declared the pandemic in March 2020, Latin America faced a paradox: it urgently needed to digitize its health systems, but it was starting from a weak technological base. The response was surprisingly swift.

Telemedicine adoption grew by more than 300% between 2019 and 2021 according to data from the Inter-American Development Bank. Countries that had no regulatory frameworks for virtual consultations created them in weeks. Colombia, Peru, Chile, and Brazil issued emergency decrees that enabled formal teleconsultation.

But the pandemic did more than just boost telemedicine. It accelerated cloud migration, electronic health record adoption, and the need for interoperability between health systems that previously operated as isolated silos.

What FIME 2019 projected for 5-10 years happened in 18 months. It was not a planned transition — it was a survival reaction that left permanent digital infrastructure in place.

What Did the Report Predict and What Actually Happened?

Artificial Intelligence: From Promise to Clinical Production

In 2019, AI in healthcare was synonymous with academic papers and research pilots. By 2026, the reality is different:

• Diagnostic imaging algorithms approved by regulators (FDA, ANVISA, INVIMA) operate in production in hospitals across Brazil, Colombia, and Mexico.
• Generative AI assists in drafting radiological reports, clinical history summaries, and initial triage.
• The global healthcare AI market exceeds $45 billion, with LATAM representing a growing share both as an adopter and as a generator of homegrown solutions.
• Natural language processing in Spanish and Portuguese has improved dramatically, enabling AI systems to be genuinely useful in the Latin American context.

The gap between what was projected and what happened is largely due to the emergence of large language models (LLMs) from 2022-2023 onward — something no 2019 report could have foreseen.

Blockchain: The Promise That Did Not Materialize (As Expected)

The FIME report bet on blockchain as the solution for medical data interoperability. Reality turned out differently: APIs and standards like HL7 FHIR proved to be more pragmatic solutions for interoperability. Blockchain found niches in pharmaceutical traceability and medical credential verification, but it did not become the backbone of clinical records as some anticipated.

Cloud-First: The New Standard

In 2019, migrating clinical data to the cloud generated distrust. By 2026, cloud-first is the standard, not the exception. Platforms like Davix, which operates on AWS infrastructure, demonstrate that the cloud offers not only scalability but also security and regulatory compliance levels superior to most local servers in Latin American hospitals.

Cloud adoption in healthcare in LATAM grew from less than 20% of institutions in 2019 to more than 60% in 2026, driven by the need for remote access, infrastructure cost reduction, and the maturation of health data regulations in the region.

LATAM in 2026: Where We Actually Stand

The digital health market in Latin America exceeds $18 billion in 2026, a figure that would have seemed fantastical in 2019. But beyond the numbers, there are fundamental qualitative changes:

Mature Regulation

• Brazil consolidated its health data framework with the LGPD and specific ANVISA regulations for software as a medical device.
• Colombia implemented Law 2015 on Interoperable Electronic Health Records, creating a national standard.
• Chile expanded its Hospital Digital program and formally regulated telemedicine.
• Mexico advances with COFEPRIS on medical software and AI device regulation.

Robust Startup Ecosystem

LATAM went from having a handful of healthtech startups in 2019 to a vibrant ecosystem. Brazil leads with more than 1,000 active healthtechs. Colombia, Mexico, Chile, and Argentina have developed digital health innovation hubs. Regional venture capital investment in healthtech exceeded $2 billion cumulative between 2020 and 2025.

Local Talent

The technical talent gap that the FIME 2019 report identified as an obstacle has narrowed. Medical informatics training programs, specialized bootcamps, and the expansion of remote work have enabled Latin American engineers to build world-class solutions without leaving the region.

Davix: A LATAM-Born Healthtech Example

Davix represents a paradigmatic case of what the region can produce. Born in Latin America, the platform offers a complete clinical management ecosystem — PACS, RIS, electronic health records, appointment management, billing, and teleradiology — on AWS cloud infrastructure.

What makes Davix relevant in this analysis is that it embodies exactly the trajectory that the FIME 2019 report anticipated as ideal but improbable: an integrated, cloud-native solution designed for the regulatory and operational realities of LATAM, with international security and interoperability standards.

What Comes Next? Trends for 2027-2030

Healthtech innovation in LATAM is not slowing down. Emerging trends include:

• Embedded clinical AI: artificial intelligence models integrated directly into clinical workflows, not as separate tools but as contextual assistants within the PACS, RIS, or electronic health record.
• Regional interoperability: efforts to enable health systems across different countries to share patient data securely, enabling cross-border healthcare.
• Accessible precision medicine: the combination of genomics, clinical data, and AI is beginning to democratize personalized medicine in the region.
• Digital health as public policy: governments moving from pilots to national implementations, with dedicated budgets and impact metrics.

Conclusion: From Gap to Opportunity

The contrast between the FIME 2019 report and the 2026 reality reveals something deeper than market figures: Latin America demonstrated that it can not only adopt health technology but create it. The R&D investment gap persists — the region still invests less than 1% of GDP compared to the OECD's 2.4% — but the efficiency with which Latin American entrepreneurs and healthcare professionals have leveraged every invested dollar defies statistics.

The next chapter of healthtech innovation in LATAM will not be written by importing solutions from the global north. It will be written with platforms born in the region, designed for its unique challenges, and scaled with the ambition to compete globally. The question is no longer whether Latin America can innovate in digital health — it is how fast it will continue to do so.